乳链菌表达系统的构建及其鉴定

南方医科大学学报 ›› 2005, Vol. 25 ›› Issue (10): 1232-1235,1239.

乳链菌表达系统的构建及其鉴定

杨晓强¹, 彭春秀², 姜泊¹, 邢锐¹, 张绍荣¹, 陈学清¹

1. 南方医科大学南方医院消化病研究所, 广东, 广州, 510515;
2. 海王英特龙生物技术股份有限公司, 广东, 深圳, 518052

出版日期:2005-10-20 发布日期:2005-10-20
基金资助:
收稿日期:2005-6-13。
基金项目:国家自然科学基金(30570839);广东省自然科学基金(05004735);广州市科委基金(2002Z3-E4101)
作者简介:杨晓强(1975- ),在读博士研究生,医师,主要从事肠道微生态的研究,E-mail:harderware@163.com
通讯作者:陈学清,电话:020-61642265,E-mail:Chenxq@vip.163.com

Construction and identification of exogenous gene expression system in Lactococcus lactis

YANG Xiao-qiang¹, PENG Chun-xiu², JIANG Bo¹, XING Rui¹, ZHANG Shao-rong¹, CHEN Xue-qing¹

1. 南方医科大学南方医院消化病研究所, 广东, 广州, 510515;
2. 海王英特龙生物技术股份有限公司, 广东, 深圳, 518052

Online:2005-10-20 Published:2005-10-20

摘要/Abstract

摘要： 目的构建可以在乳链菌表达外源性基因的系统。方法采用基因拼接方法拼装含有P59启动子、USP45蛋白信号肽及多克隆位点的基因序列,并将其连入质粒pBluescript IISK(+)以形成重组质粒pBS-PU,PCR扩增USP45终止子并连接至质粒pBS-PU构建可将外源性基因分泌表达于菌体外的质粒pNBC1000,PCR扩增M6基因随后连接至pNBC1000构建可将外源性基因分泌表达于菌体外及锚定表达于细胞壁的质粒pNBC2000。通过将增强绿色荧光蛋白(EGFP)基因连接至质粒pNBC2000,激光共聚焦显微镜下观察含有pNBC2000-EGFP质粒及对照质粒的细菌,验证EGFP定位表达情况。结果所构建的表达系统可以表达EGFP基因。结论通过基因拼接方法成功构建了乳链菌表达系统,其可将外源性基因分泌表达于菌体外。

Abstract: Objective To construct and characterize an exogenous gene expression system in Lactococcus lactis. Methods PCR-based gene assembly was used to synthesize the gene sequence containing P59 promoter, USP45 signal peptide, ribosome binding site and multiple cloning site. Plasmid pBS-pu was obtained after ligation of the assembled sequence with pBluescriptⅡ SK (+), and the terminator of USP45 protein was added to construct the recombinant plasmid pNBC1000. The gene coding for Streptococcus pyogenes M6 protein was amplified and cloned into pNBC1000 to obtain the plasmid pNBC2000. To characterize the expression system, enhanced green fluorescent protein (EGFP) gene was amplified from the plasmid pEGFP-N1 and cloned into pNBC2000. Laser scanning confocal microscope was used to observe the bacteria containing pNBC2000, pNBC2000-EGFP or pBS-EGFP. Results Green fluorescence wad wisualized in the bacteria containing pNBC2000-EGFP, but not in the bacteria containing pNBC2000 or pBS-EGFP. Conclusion The plasmids pNBC1000 and pNBC2000 containing P59 promoter, USP45 signal peptide, ribosome binding site and multiple cloning sites are successfully constructed, which are capable of expressing exogenous gene in Lactococcus lactis.

中图分类号:

Q939.11

杨晓强¹, 彭春秀², 姜泊¹, 邢锐¹, 张绍荣¹, 陈学清¹. 乳链菌表达系统的构建及其鉴定[J]. 南方医科大学学报, 2005, 25(10): 1232-1235,1239.

YANG Xiao-qiang¹, PENG Chun-xiu², JIANG Bo¹, XING Rui¹, ZHANG Shao-rong¹, CHEN Xue-qing¹. Construction and identification of exogenous gene expression system in Lactococcus lactis[J]. Journal of Southern Medical University, 2005, 25(10): 1232-1235,1239.

参考文献

[1] Chatel JM, Nouaille S, Adel-Patient K, et al. Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in mice [J].Appl Environ Microbiol, 2003, 69( 11): 6620-7.
[2] Bolotin A, Wincker P, Mauger S, et al. The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403[J]. Genome Res, 2001, 11(5): 731-53.
[3] Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10[J]. Science, 2000, 289:1352-5.
[4] Steidler L, Neirynck S, Huyghebaert N, et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10[J]. Nat Biotechnol, 2003, 21 (7):785-9.
[5] Vandenbroucke K, Hans W, van Huysse J, et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevants and heals actue colitis in mice[J]. Gastroenterology, 2004, 127(2):502-13.
[6] van der Vossen JM, van der Lelie D, Venema G, et al. Isolation and characterization of Streptococcus cremoris Wg2-specific promoters [J]. Gene, 1987, 53(10): 2452-7.
[7] van Asseldonk M, Rutten G, Oteman M, et al. Cloning ofusp45, a gene encoding a secreted protein from Lactococcus lactis subsp.lactis MG1363[J]. Gene, 1990, 95(1): 155-60.
[8] Simon D, Chopin A. Construction of a vector plasmid family and its use for molecular cloning in Streptococcus lactis [J]. Biochimie,1988, 70(4): 559-66.
[9] Samal BB, Arakawa T, Boone TC, et al. High level expression of human leukemia inhibitory factor (LIF) from a synthetic gene in Escherichia coli and the physical and biological characterization of the protein[J]. Biochim Biophys Acta, 1995, 1260(1): 27-33.
[10] Barnes WM. PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates [J]. Proc Natl Acad Sci USA, 1994, 91(6): 2216-20.
[11] Ribeiro LA, Azevedo V, Le LY, et al. Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grad live vaccines against Brucellosis [J]. Appl Environ Microbiol, 2002, 68(2): 910-6
[12] Mannam P, Jones KF, Geller BL. Mucosal vaccine made from live,recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes [J]. Infect Immun, 2004, 72(6): 3444-50.
[13] Pei H, Liu J, Cheng Y, et al. Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination [J]. Appl Microbiol Biotechnol, 2005, 68(2): 220-7.
[14] 凌均棨,汪喻忠,蒋少云,等.基因重组乳链菌防龋疫苗免疫性的实验研究[J].中山医科大学学报,2000,2l(4):241-4.Ling JQ, Wang YZ, Jiang SY. Experimental study on the immunity of recombinant Streptococcus lactis anticaries vaccine [J]. Acad J SUMS, 2000, 21(4): 241-4.
[15] Dieye Y, Usai S, Clier F, et al. Design of a protein-targeting system for lactic acid bacteria[J]. J Bacteriol, 2001, 183(14): 4157-66.
[16] Stemmer WP, Crammeri A, Ha KD, et al. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides[J]. Gene, 1995, 164(1): 49-53.